Aquaporin-4 (AQP-4) is the principal brain water channel and is predominantly expressed in astrocytes suggesting its dynamic involvement in water homeostasis in brain tissue. Due to the co-localization of AQP-4 and inward rectifier K þ channels Kir 4.1, a functional coupling between these proteins has been proposed. AQP-4 has a putative role in the physiopathology of brain disorders including epilepsy and trauma. S100B is a calcium-binding protein expressed and secreted by astrocytes, and commonly used as a parameter of astroglial activation. Here, we investigate a possible link between AQP-4 activity (and Kir 4.1) and S100B secretion in hippocampal slices of rats of different ages using non-specific inhibitors of AQP-4 (AZA, acetazolamide and TEA, tetraethylammonium) and Kir 4.1 (barium chloride). We found that blockade of AQP-4 with TEA and AZA produced an increase in S100B secretion in young rats, compatible with an astroglial activation observed in many conditions of brain injury. On the other hand, BaCl 2 induced Kir 4.1 inhibition caused a decrease in S100B secretion. Both channels, AQP-4 and Kir 4.1, exhibited a similar ontogenetic profile, in spite of the functional uncoupling, in relation to S100B secretion. Moreover, we found a significant increase in the S100B secretion basal levels with the increasing of animal age and the incubation with high levels of potassium resulted in a decrease of S100B secretion in 30 and 90-day old rats. These data, together with previous observations from gap junctions and glutamate transport of astrocytes, contribute to characterize the operational system involving astroglial activation, particularly on S100B secretion, in brain disorders.
Introduction
Aquaporin-4 (AQP-4) is the principal brain water channel, and is predominantly expressed in astrocytes and ependimal cells. The elevated expression of AQP-4 in astrocytes surrounding synapses and capillary vessels suggests its dynamic involvement in water homeostasis in the brain tissue (Medici et al., 2011) . This aquaporin has gained much attention due to its putative role in the physiopathology of brain disorders including ischemia, epilepsy and traumatic brain disease, tumor-induced brain swelling, infections and hydrocephalus (Papadopoulos and Verkman, 2007) . Due to the co-localization between the AQP-4 and potassium channels, particularly subtype 4.1 of the inwardly rectifier K þ channels (Kir 4.1), a functional coupling between these proteins has been proposed (e.g. Nagelhus et al., 2004) . Astrocytes express multiple Kir channel subtypes; however, Kir 4.1 is predominantly expressed in these cells and it seems to be the primary mechanism in maintaining the extracellular K þ homeostasis needed for sustained neuronal excitability (Ohno et al., 2007) .
There is some evidence of the coupling between Kir 4.1 and AQP-4. For example, a mislocalization of AQP-4 in transgenic mice was accompanied by a delayed K þ clearance (Amiry- Moghaddam et al., 2003) . In spite of this close functionality, the mechanism that allows an interaction between these channels remains poorly understood. Moreover, the coupling between these channels was not found in cultured hippocampal astrocytes (Zhang and Verkman, 2008) .
Three years ago, it was proposed that S100B, a calcium-binding protein also expressed in astrocytes, could modulate the expression of AQP-4 (Esposito et al., 2008) . S100B is a very soluble protein of 21 kDa . Intracellularly, many putative protein targets of S100B have been characterized, particularly modulating cytoskeleton plasticity and cell proliferation. At sub-nanomolar concentrations, extracellular S100B stimulates in vitro neurite growth, glial proliferation and promotes neuronal survival. However, elevated levels of this protein (particularly in cerebrospinal fluid and serum) have been associated with astroglial activation in conditions of brain injury . Although the mechanism of S100B secretion remains unknown, some secretagogues [e.g. gapjunction inhibitors ] have been identified in glial cell cultures and acute brain slices and these help us to interpret changes in the extracellular content of this protein.
Beyond the data suggesting an AQP-4-induced expression by S100B (Esposito et al., 2008) , other clues reinforce a putative connection between S100B and AQP-4. For example, interleukin 1-beta increases the expression of AQP-4 (Ito et al., 2006) and it is able to modulate S100B secretion in astrocytes and hippocampal slices . Interestingly, in neuromyelitis optica (NMO), a severe auto-immune demyelinating disease, in which anti-AQP-4 antibodies are produced (Jarius et al., 2008) , an increase in cerebrospinal fluid S100B was observed in relapsing patients (Misu et al., 2009 ). However, no data are available regarding any direct connection between AQP-4 (or its cooperant channel Kir 4.1) and S100B secretion.
Herein, we investigated whether changes in AQP-4 and/or Kir 4.1 activity, using non-specific inhibitors of these channels, could modulate S100B secretion in hippocampal slices, and whether such modulation would be related to the agedependent expression of these channels. Moreover, we observed the ontogenetic profile of S100B secretion and the changes on S100B secretion in hippocampal slices when incubated with high levels of potassium.
Results
As shown in Fig. 1 , hippocampal slices from 15 or 30-days old rats incubated with AQP4 inhibitor, TEA, at 10 (Fig. 1A ) or 1000 mM (Fig. 1B ) demonstrated an increase in S100B secretion. However, S100B secretion from hippocampal slices of older animals (45, 60 or 90-days old rats) was not affected by the presence of this inhibitor. The integrity and viability of these slices were evaluated by LDH and MTT reduction activity assays, respectively (data not shown). Using AZA, another inhibitor of AQP4, we also observed an increase in S100B secretion (Fig. 2) . At 1 mM AZA, S100B secretion significantly increased only in hippocampal slices of 15-day old rats (Fig. 2A) . However, at 100 mM AZA, the increase in S100B secretion was observed in 15, 30 and 45-days old rats (Fig. 2B) . It is important to mention that DMSO at 0.01%, the vehicle for AZA, did not alter the basal S100B secretion at any age analyzed (data not shown).
Due to the functional connection between AQP4 and potassium channels, we investigated a possible effect of barium on S100B secretion in hippocampal slices of rats of different ages (Fig. 3) . When hippocampal slices were incubated with 100 mM barium chloride, we observed a decrease in S100B secretion in the younger rats (15 to 45-days old rats) (Fig. 3A) . However, at 1000 mM, barium was able to decrease S100B secretion in the hippocampal slices of rats at all ages analyzed (Fig. 3B) .
We then investigated the effects of both TEA (positive effect) and barium chloride (negative effect) on S100B secretion (Fig. 4) . When TEA (at 10 mM) and barium chloride (also at Fig. 1 -Effect of TEA on S100B secretion in hippocampal slices. Hippocampal slices from Wistar rats of different ages (15, 30, 45, 60 and 90-days old) were exposed to TEA at concentrations of 10 lM (A) and 1000 lM (B) for 1 h. S100B was determined by ELISA. The line indicates basal secretion, assumed as 100%, in each experiment. Each value is a mean (7 standard error) of 6 independent experiments performed in triplicate. Ã Significantly different from basal secretion po0.05 compared to control (ANOVA followed by the Tukey's test).
10 mM) were administered, an increase of S100B secretion was observed only in hippocampal slices of 15-day old rats (Fig. 4A) . However, when hippocampal slices were incubated TEA (at 10 mM) and barium chloride at 1000 mM, the negative effect on S100B secretion was predominant and observed for all ages analyzed (Fig. 4B) .
In order to evaluate the immunoreactivity for AQP4 and Kir 4.1, we carried out an AQP4 and Kir 4.1 immunohistochemical study. The photomicrographs of AQP4 and Kir 4.1 indicate the immunofluorescence for these proteins (Fig. 5A , B, D and E) and when we analyzed these images by confocal microscopy, we observed the co-localization of AQP4 and Kir 4.1 in an astrocyte ( Fig. 5C and E). When we analyzed the expression from these proteins in hippocampi from 15 and 90-day old rats, we found a similar distribution pattern in young and adult rats (Fig. 6) .
Subsequently, we quantified by western blotting the immunocontent for these proteins in rats of 15, 30, 60 and 90 days old. We observed a decrease in AQP4 expression in 90-day old rats when compared with the younger animals ( Fig. 7A ). The immunocontent for Kir 4.1 was decreased in 30, 60 and 90-day old rats, compared with 15-day old animals (Fig. 7B) . Fig. 8 Due the changes in the main potassium channel present in astrocytes (kir 4.1) during the development and the possible connection between potassium and S100B, two-way ANOVA was conducted to investigate the S100B secretion in hippocampal slices from 15, 30 and 90-day old rats when exposed to a high concentration of potassium. We observed the significant interaction between treatment and age, thus we performed the simple main effect test. The high potassium concentration incubated in hippocampi of 15-day old animals promoted a tendency of increase in S100B secretion when compared with the control. So, when we used slices from 30 and 90-day old animals, the incubation with high potassium resulted in a decrease of S100B secretion. Moreover, we observed a significant increase the S100B secretion basal levels with the increasing of animal age.
Discussion
Aquaporin-4, the main water channel of astrocytes, is localized in the plasmatic membrane surrounding capillaries and synapses, and is a key component in the pathogenesis of brain edema, commonly associated with ischemic and traumatic brain injury (Perez et al., 2007) . During acute transient arterial occlusion in rats, a rapid loss (about 2 h) of AQP-4 was observed in a specific area of vascular damage (Friedman et al., 2009 ). Other studies in trauma models of brain injury also showed a decrease in AQP-4, followed by an increase in this protein (e.g. Ke et al., 2001) . Apparently this initial decrease could reflect a mechanism of self-protection avoiding the brain swelling (Friedman et al., 2009 ). On the other hand, the recovery of brain tissue seems to involve the up-regulation of AQP-4 observed later on. Commonly, many clinical and experimental conditions of brain injury are accompanied by elevation of peripheral S100B, which in turn are interpreted as being due to the astroglial activation . In fact, acute S100B release could work as a neurotrophic factor to neighbor cells ) and/or as an alarmin, i.e., a warning signal of danger (Bianchi et al., 2007) . However, to date, no direct link between the decrease in AQP-4 function and the increase in extracellular S100B has been investigated. Our results in hippocampal slices from young rats show that a decrease in AQP-4 activity (induced by non-specific inhibitors) was accompanied by an increase in S100B secretion. An initial increase of S100B in brain injury has been proposed not only as a warning signal for newborn cells, but also as a factor released for protection and neural survival Goncalves et al., 2010) . Therefore, we may suppose that S100B release from astrocytes, at least in part, could result from decreased AQP-4 activity. The mechanism involved in the S100B secretion is unclear, as well as the signaling involved. However, the interaction maybe involve a calcium-mediated signaling pathway initiated by water influx through the AQP-4 (Thrane et al., 2011) , assuming that S100B secretion seems to be an event that is dependent on calcium (Davey et al., 2001; Nardin et al., 2009) .
In this study, we used two classes of aquaporin-4 inhibitors: TEA (from a class of quaternary ammonium salts) and AZA (a sulfonamide) (Haddoub et al., 2009 ). These are non- Fig. 4 -Effect of TEAþBaCl 2 on S100B secretion in hippocampal slices. Hippocampal slices from Wistar rats of different ages (15, 30, 45, 60 and 90-days old) were exposed to TEA and BaCl 2 at concentrations of 10 lM (A) and 1000 lM (B) for 1 h. S100B was measured by ELISA. The line indicates basal secretion, assumed as 100%, in each experiment. Each value is a mean (7standard error) of 6 independent experiments performed in triplicate. Ã Significantly different from basal secretion po0.05 compared to control (ANOVA followed by the Tukey's test). specific inhibitors for aquaporin-4 inhibitors. Currently, there are no specific inhibitors for aquaporins and transgenic animals have been used try to overcome this problem [e.g. (Tamma et al., 2012) ]. TEA is able to inhibit aquaporins subtypes 1, 2 and 4, but not 3 and 5 at low concentrations (1-10 mM) (Detmers et al., 2006) . Although these compounds are active inhibitors for sub-type 4 aquaporin (found in astrocytes), molecular targets other than aquaporins have been described for these compounds (Huber et al., 2009) . Notice that TEA has an IC 50 of 9.8 mM for AQP-4 (Detmers et al., 2006) and, under our conditions (at 10 and 1000 mM), this compound stimulated S100B secretion. It has been reported that TEA, at concentrations of higher than 1 mM, is able to inhibit K þ channels (Detmers et al., 2006) . However, when we blocked K þ channels using BaCl 2 a decrease in S100B secretion was observed. AZA has an apparent IC 50 of 0.9 mM for AQP-4 (Huber et al., 2007) and it is widely used a carbonic anhydrase inhibitor at 1 mM. On the other hand, no direct effect of TEA has been reported, to our knowledge, on carbonic anhydrase. Therefore, the common effect of TEA and AZA on S100B secretion does not likely involve anhydrase carbonic inhibition. On the contrary, an antagonism between these compounds has been reported: high levels of TEA (at 500 mM, therefore acting on K þ channels) were able to inhibit AZA-induced vasodilatation (Pickkers et al., 2001) . Together, the effects of TEA and AZA indicate a putative inhibition of AQP-4 under our conditions. We cannot rule out that other targets of these compounds are involved in the secretion of S100B. Nevertheless, both TEA and AZA, at concentrations used for AQP-4 inhibition (at 10 mM and 1 mM, respectively), stimulated S100B secretion in hippocampal slices from young rats. It is, therefore, reasonable to conceive that the TEA and AZA-induced S100B secretion is linked to AQP-4 inhibition.
Interestingly, in agreement with the stimulatory effect on S100B secretion observed in young rats, the ontogeny of AQP-4, evaluated by Western blotting, was found to be more elevated in young rats (15-30 and 60-days old) than in adult rats (90-days old). This link, observed in vitro, between AQP-4 inhibition and S100B secretion cannot help to explain the unchanged levels of serum S100B that we observed in relapsing NMO patients, where elevated levels of anti-AQP-4 antibodies are produced (Robinson-Agramonte et al., 2010). However, conversely and in agreement with our present data, other studies found increased levels of cerebrospinal fluid S100B in NMO disease (e.g. Misu et al., 2009 ). This discrepancy between serum and cerebrospinal fluid samples reinforces the idea that other cell sources of S100B, beyond astrocytes, contribute to serum S100B .
Another aspect investigated in this work was the putative functional association of glial K þ channel Kir 4.1 with AQP-4.
In fact, the ontogeny of these proteins, investigated here by Western blotting, reinforces the idea of a close interaction between them. The idea of a structural and functional interaction between Kir 4.1 and AQP-4 is supported by some evidence (see Nagelhus et al., 2004) . For example, membrane co-localization (Nagelhus et al., 1999) and delayed K þ clearance in transgenic mice exhibiting mislocalization of AQP-4 (Amiry- Moghaddam et al., 2003) . However, some controversy surrounds these findings. For example, no changes in the electrophysiology of Muller cells were observed in AQP-4 knockout mice (Ruiz-Ederra et al., 2007) and no changes in water permeability were observed in hippocampal astrocytes incubated with BaCl 2 (Zhang and Verkman, 2008) . The inhibition of Kir 4.1 (by BaCl 2 ), in contrast to the inhibition of AQP-4, caused a decrease in S100B secretion in hippocampal slices from young rats. This argues against a functional coupling between Kir 4.1 and AQP-4. Notice that at high concentrations of BaCl 2 (1 mM) the inhibition of S100B secretion was predominant over the TEA stimulatory effect. Assuming acute S100B release as being a warning signal or a protective factor to neighboring cells, it is difficult to conceive that an impairment of Kir channels results in a decrease of S100B. In fact, the inhibition of two important astrocyte activities such as glutamate transport and gap junctions resulted in S100B release Tramontina et al., 2006) . Moreover, Kir inhibition by BaCl 2 is accompanied by a reduction of glutamate uptake (Kucheryavykh et al., 2007) , and glutamate uptake was reduced in Kir 4.1 knockout mice (Djukic et al., 2007) . These data, together, could suggest that Kir inhibition may result in an increase in S100B release. In addition, our findings demonstrate that inhibition of aquaporin-4, which functionally interacts with gap junctions and Kir channels (Lichter-Konecki et al., 2008) , also resulted in increased S100B release. A possible explanation for this would be that Kir channel impairment directly affects the mechanism of S100B secretion, which remains unknown . Further experiments will confirm, or not, this possibility. Moreover, the effect of BaCl 2 is not limited to Kir channels and BaCl 2 could be affecting S100B secretion, independently of an effect on Kir channels.
Moreover, it is important to mention that, in two other conditions that could result from neuronal hyperactivity, elevated glutamate (e.g. 1 mM) or K þ (e.g. 30 mM) also leads to a decrease in S100B release in brain slices (Buyukuysal, 2005; Nardin et al., 2009) which is in agreement with our results in hippocampal slices of 30 and 90-day old rats incubated with K þ high concentration. In support of these findings, accumulation of K þ in hippocampal slices after traumatic brain injury attributed to a decrease in Kir currents was also observed in control slices incubated with BaCl 2 (D' Ambrosio et al., 1999) . Finally, it important to comment that a connection between astrocyte S100B release and AQP-4 activity could be clinically useful in the future and could allow the correlation of these in vitro and in vivo parameters of S100B release, considering the necessity for the development of therapeutic AQP-4 inhibitors and the current limitations of measurements of water permeability (Haddoub et al., 2009 ). Brain disorders involving fluid imbalances and edema have stimulated the search for AQP targets and specific inhibitors, which currently are not available (Yool et al., 2010) .
In summary, we show that blockade of AQP-4 with TEA and AZA (at 10 mM and 1 mM, respectively) in hippocampal slices from young rats produced an increase in S100B secretion, compatible with the astroglial activation observed in many conditions of brain injury. Conversely, inhibition of Kir 4.1 b Different from 15, 30 and 60 post-natal days rats (ANOVA followed by the Tukey's test). Fig. 8 -Effect of high potassium on S100B secretion in hippocampal slices of rats from different ages. Hippocampal slices from Wistar rats of different ages (15, 30, 45, 60 and 90-days old) were exposed to KCl at concentrations of 30 mM for 1 h. S100B was measured by ELISA. Each value is a mean (7standard error) of 6 independent experiments performed in triplicate. Ã Different letters indicate significant statistical difference among ages and treatment with high potassium (two-way ANOVA followed by simple main effect test if interaction was positive).
channels with BaCl 2 (at 100 mM) resulted in a decrease in the secretion of S100B. Both AQP-4 and Kir 4.1 channels exhibited a similar ontogenetic profile, in spite of the functional uncoupling in relation to S100B secretion. These data, together with other observations from gap junctions and glutamate transport of astrocytes, contribute to characterize the operational system involving astroglial activation, particularly in S100B secretion during conditions of brain injury.
Experimental procedures

Animals
Wistar rats were obtained from our breeding colony, maintained under controlled light and environmental conditions (12 h light/12 h dark cycle at a constant temperature of 2271 1C) and had free access to a 20% (w/w) protein commercial chow and water. All animal experiments were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications no. 80-23) revised 1996, following the regulations of the local animal house authorities.
Material
Polyclonal anti-S100 antibody, polyclonal anti-AQP-4 antibody and polyclonal anti-Kir 4.1 were purchased from DAKO (Glostrup, Denmark), Chemicon (Temecula, USA) and Santa Cruz Biotechnology (Santa Cruz, USA) respectively. The antibodies peroxidase-conjugated IgGs were obtained from Amersham (Buckingamshire, UK), Alexa fluor (568) and Alexa fluor (488) were purchased from Invitrogen (Carlsbad, USA). Monoclonal anti-S100B antibody (SH-B1), 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid, [3(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] (MTT) and o-phenylenediamine were purchased from Sigma (St. Louis, USA). Tetraethylammonium chloride (TEA) and barium chloride (BaCl 2 ) were obtained from Merck (Whitehouse Station, USA), acetazolamide (AZA) from Alfa-aesar (Ward Hill, USA) and KCl from Vetec (Duque de Caxias, Brasil).
Preparation of hippocampal slices
Wistar rats (15, 30, 45, 60 and 90 days-old) were killed by decapitation, the brains were removed and placed in cold saline medium with the following composition (in mM): 120 NaCl; 
Western blotting
Equal amounts (20 mg) of proteins from each sample were boiled in sample buffer (0.0625 M Tris-HCl, pH 6.8, 2% (w/v) SDS, 5% (w/v) b-mercaptoethanol, 10% (v/v) glycerol, 0.002% (w/v) bromophenol blue) and electrophoresed in 10% (w/v) SDS-polyacrylamide gel. The separated proteins were blotted onto a nitrocellulose membrane. Equal loading of each sample was confirmed with Ponceau S staining (Sigma) ). Anti-AQP-4 (Chemicon) or anti-Kir 4.1 (Santa Cruz Biotechnology) were used at a dilution of 1:1000. After incubating with the primary antibody for 1 h at room temperature, filters were washed and incubated with peroxidase-conjugated anti-rabbit immunoglobulin (IgG) or peroxidase-conjugated anti-goat immunoglobulin (IgG) at a dilution of 1:2000. The chemiluminescence signal was detected using an ECL kit from Amersham.
ELISA for S100B
The S100B concentration was determined in the incubation medium of slices at 1 h. The ELISA for S100B was carried out, as described previously . Briefly, 50 mL of sample plus 50 mL of Tris buffer were incubated for 2 h on a microtiter plate previously coated with monoclonal anti-S100B. Polyclonal anti-S100 was incubated for 30 min and then peroxidaseconjugated anti-rabbit antibody was added for a further 30 min. The color reaction with o-phenylenediamine was measured at 492 nm. The standard S100B curve ranged from 0.002 to 1 ng/mL.
4.6.
Immunohistochemistry for AQP4 and Kir 4.1
Rats were anesthetized using ketamine/xylazine and were perfused through the left cardiac ventricle with 200 mL of saline solution, followed by 200 mL of 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. The brains were removed and left for post-fixation in the same fixative solution at 4 1C for 2 h. After this, the material was cryoprotected by immersing the brain in 30% sucrose in phosphate buffer at 4 1C (Rodrigues et al., 2009 ). The brains were sectioned (50 mm) on a cryostat (Leitz) and sections were then pre-incubated in 2% bovine serum albumin in phosphate buffered saline containing 0.3% Triton X-100 for 30 min. The sections were incubated with polyclonal anti-AQP4 from rabbit, diluted 1:300 in 2% bovine serum albumin in phosphate buffer-Triton X-100, for 48 h at room temperature. After washing several times, tissue sections were incubated with polyclonal anti-Kir 4.1 from goat, diluted 1:300 for 48 h. Subsequently, an Alexa fluor (568) secondary antibody, diluted 1:200 in phosphate buffer was incubated at room temperature for 2 h and then Alexa fluor (488) for a further 2 h. Afterwards, the sections were mounted on slides with Fluor save and covered with coverslips. Immunoreactions for AQP-4 and Kir 4.1 in the stratum radiatum of the CA1 hippocampal region (identified based on intraural coordinates 5.86 to 4.16 mm, bregma À3.14 to À4.16 mm) (Paxinos and Watson, 1998) were observed.
4.7.
Other measurements Extracellular S100B content was referred to as ''secretion'', based on the cell integrity measurement (data not shown), by measuring lactate dehydrogenase (LDH) activity with a colorimetric commercial kit (from Doles, Brazil) and the colorimetric MTT method (Hansen et al., 1989) .
Statistical analysis
Data from the experiments are presented as means7stan-dard error and was analyzed statistically by one-way analysis of variance (ANOVA) followed by posthoc analyzes (Tukey's test) or by two-way analysis of variance followed by simple main effect test if interaction was positive when indicated.
Results from control conditions (0.01% dimethyl sulfoxide) used in the figures were not different from those obtained under basal conditions without dimethyl sulfoxide. Values of po0.05 were considered to be significant. All analyses were carried out using the Statistical Package for Social Sciences (SPSS) software.
